• Home
  • Leadership
  • Policy Areas
  • Resources
Press Releases
07.01.25

RDCC Calls on Congress to Maintain Vital ORPHAN Cures Act in Final Reconciliation Package

Read more
Press Releases
05.23.25

RDCC Applauds Senate Introduction of ORPHAN Cures Act

Read more
Press Releases
02.19.25

RDCC Supports Bipartisan Introduction of Cameron’s Law

Read more
Press Releases
02.13.25

RDCC Applauds Bipartisan Effort to Reauthorize Rare Pediatric Disease Priority Review Voucher Program

Read more
News
12.18.24

Rare Disease Company Coalition (RDCC) Urges Passage of Continuing Resolution to Reauthorize Rare Pediatric Disease Priority Review Voucher Program

Read more
News
11.04.24

RDCC Comments on Advancing Rare Disease Therapies Through a FDA Rare Disease Innovation Hub

Read more
News
09.12.24

Rare Disease Biotech Innovators Urge Timely Reauthorization of Rare Pediatric Disease Priority Review Voucher (PRV) Program

Read more
News
08.02.24

RDCC’s Response to 21st Century Cures Act and Cures 2.0 Request for Information

Read more
Press Releases
07.29.24

Rare Disease Company Coalition Statement Applauding FDA’s Establishment of Rare Disease Innovation Hub

Read more
Press Releases
05.22.24

Stacey Frisk Named as New Executive Director of the Rare Disease Company Coalition

Read more
Press Releases
04.08.24

RDCC Endorses Bipartisan Accelerating Kids’ Access to Care Act

Read more
Press Releases
02.21.24

RDCC Supports Bipartisan Effort to Reauthorize Rare Pediatric Disease Priority Review Voucher Program

Read more
News
01.25.24

RDCC Submits Response to Senator Cassidy’s Request for Information on “Improving Americans’ Access to Gene Therapies”

Read more
News
11.15.23

ORPHAN Cures Act Enables Rare Disease Companies to Pursue Promising Research to Uncover More Treatment Options

Read more
Press Releases
11.15.23

Graham Owens Announced as Executive Director of the Rare Disease Company Coalition

Read more
Press Releases
10.26.23

Rare Disease Company Coalition Urges Congressional Action in Capitol Hill Briefing on the Risks of Rare Disease Drug Development

Read more
Press Releases
06.30.23

Revised Inflation Reduction Act Guidance Increases Risk of Rare Disease Drug Development

Read more
Press Releases
03.03.23

RDCC Applauds Reintroduction of Cameron’s Law and the Rare Disease Clinical Trial Pandemic Disruption Act

Read more
Press Releases
02.16.23

RDCC Responds to New HHS Payment Models Targeting Accelerated Approval Therapies

Read more
Press Releases
01.03.23

Recognizing the 40th Anniversary of the Orphan Drug Act, The Rare Disease Company Coalition Calls on Policymakers to Renew Commitment to Advancing Innovation for Rare Disease Patients

Read more
Press Releases
06.06.22

Amanda Malakoff Announced as Executive Director for the Rare Disease Company Coalition

Read more
Press Releases
02.03.22

The Rare Disease Company Coalition Announces 2022 Executive Committee and Leadership Appointments

Read more
Press Releases
12.15.21

The Rare Disease Company Announces New Members and Continues Growth in its Inaugural Year

Read more
Press Releases
11.17.21

Introduction of Cures 2.0 Applauded by Coalition Dedicated to Rare Disease Treatment Development with Call to Congress to Recognize Both Challenges and Opportunities in Rare Disease R&D

Read more
Press Releases
11.03.21

Congressional Leaders Continue to Place Politics Over Rare Disease Patients with Proposed Changes to Orphan Drug Tax Credit in Build Back Better Act

Read more
Press Releases
10.12.21

The Rare Disease Company Coalition Continues Growth and Announces New Members

Read more
Press Releases
09.14.21

The Rare Disease Company Coalition Issues Statement Citing Proposed Changes to Orphan Drug Tax Credit in Build Back Better Act Would Deliver Devastating Blow to Rare Disease Patients and Companies Dedicated to Delivering Innovative Treatments for Them

Read more
Press Releases
08.12.21

The Rare Disease Company Coalition Urgently Calls On the White House and Congress to Recognize the Unmet Needs of Rare Disease Patients as Drug Pricing Policy Proposals are Considered

Read more
Press Releases
07.29.21

The Rare Disease Company Coalition Urges Congress to Preserve and Reinforce Accelerated Approval Program to Enable Delivery of Therapies for Challenging Rare Diseases

Read more
Press Releases
06.30.21

The Rare Disease Company Coalition Announces New Members

Read more
Press Releases
06.22.21

The Rare Disease Company Coalition Applauds Introduction of Cures 2.0 and Encourages Congress to Account for the Unique Circumstances in Rare Disease Treatment Development

Read more
Press Releases
06.07.21

The Rare Disease Company Coalition Announces 2021 Executive Committee

Read more
Press Releases
05.13.21

The “Rare Disease Company Coalition” Launches to Share the Unique Challenges and Promise of Rare Disease Therapy Development to Support Continued Progress and Patient Access

Read more

©2025 The Coalition for Research, Access, Reform, and Equality for Rare Diseases (RARE). All rights reserved.

Privacy Policy